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CONDENSATION 
Relative to the first hour of expulsive efforts, chances of spontaneous vaginal delivery 
decrease every hour, while maternal risks increase.  
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ABSTRACT  
Objective: To assess the influence of the duration of active second stage on maternal 
and neonatal outcomes.  
Study design: Secondary analysis of the PEOPLE trial including 1862 second stage 
nulliparous women with epidural. According to duration of active second stage, we 
estimated the proportion of spontaneous vaginal deliveries (SVD) with a newborn without 
signs of asphyxia (5 minutes Apgar score≥7 and arterial pH>7.10). We also analyzed 
maternal and neonatal outcomes according to duration of expulsive efforts. 
Results: Relative to the first hour of expulsive efforts, the chances of a SVD of a 
newborn without signs of asphyxia decreased significantly every hour (1-2h:adjusted 
OR=0.4[0.3-0.6], 2-3h:adjusted OR=0.1[0.09-0.2], >3h:adjusted OR=0.03[0.02-0.05]). 
The risk of postpartum hemorrhage and intrapartum fever increased significantly after 2h 
of pushing. 
Conclusion: Faced with a decreasing probability of SVD and increased maternal risk of 
morbidity after 2 hours, we raise the question as to whether expulsive efforts should be 
continued after this time. 
 
Key words: duration of active second stage; nullipara; maternal complications
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INTRODUCTION 
 
The second stage commences at full dilatation and is divided into two phases: the 
passive second stage when the fetal head progresses passively in the maternal pelvis and 
the active second stage which corresponds to the phase of active expulsive efforts. 
Prolonged second stage (more than 2 or 3 hours according to the authors) is associated 
with an increased risk of maternal complications, operative vaginal delivery, perineal 
trauma, chorioamnionitis, postpartum hemorrhage, but not with an increased risk of 
adverse neonatal outcomes (1-7). However, in most studies related to prolonged second 
stage, passive and active second stages were not differentiated. Because the point of 
onset of the 2nd stage is difficult to determine, especially when the vaginal examinations 
during labor are less frequent, a measurement bias in these studies cannot be excluded 
(8). Conversely, the time of commencing expulsive efforts is usually accurately 
documented. As regards the management of the second stage, no previous cohort study 
has specifically analyzed maternal and neonatal outcome indicators as a function of the 
duration of the active phase of the second stage of labor. 
 
Several trials have been published about the management of the second stage as regards 
a policy of immediate or delayed pushing, with controversial results. The PEOPLE trial 
(Pushing Early Or Pushing Late with Epidural) is one such trial (9). A meta-analysis of 
these trials found a decreased risk of rotational or mid-pelvic instrumental deliveries in 
the delayed pushing group, but non significant reductions of instrumental deliveries, 
caesarean section and adverse neonatal outcomes (10). The authors of that meta-
analysis concluded that there is a benefit of delayed pushing in hospitals with high rates 
of rotational or mid-pelvic procedures, but no advantage in hospitals with low rates of 
these procedures. Thus, there are still today considerable variations in management of 
the second stage according to hospital protocols, obstetricians‟ habits and experience. 
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With respect to duration of the active phase of the second stage, we hypothesized that 
after a certain duration of pushing, maternal and neonatal risks may outweigh the 
benefits of continued pushing.  
 
The purpose of our study was to evaluate the rate of spontaneous vaginal delivery with a 
newborn without signs of asphyxia according to the duration of the active second stage. 
We also assessed the influence of the duration of active second stage on maternal and 
neonatal outcomes, to try to determine a “maximal” duration of pushing efforts, 
adjusting for the second stage management, delayed or immediate pushing.  
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MATERIALS & METHODS 
 
We conducted a secondary analysis of all patients (n=1862) included in the PEOPLE trial, 
a multicenter randomized controlled trial comparing early and delayed pushing with 
epidural, between October 1994, and September 1996, in 12 academic centers (10 in 
Canada, 1 in the United States, and 1 in Switzerland). Nulliparous women at term (≥ 37 
weeks) with a singleton vertex fetus were eligible and randomized at the beginning of the 
second stage. Exclusion criteria were abnormal fetal heart rate monitoring during the first 
stage, maternal fever during the first stage of labor, adverse events during the 
pregnancy (hypertension, hemorrhage, fetal malformation, intra uterine growth 
retardation) and any condition that necessitated shortening of the second stage of labor 
(9). The clinical trial was approved by the Ethics Committee of Laval University. 
 
The management of the passive phase of the second stage was standardized. In the 
early pushing group, women were encouraged to commence pushing immediately on 
random assignment. In the late pushing group, women were advised to avoid voluntary 
expulsive efforts for 2 hours unless they felt an irresistible urge to push, the fetal head 
was visualized at the inspection of the perineum or a medical indication to shorten the 
second stage of labor developed. However, there was no standardized management with 
respect to pushing technique. For women without oxytocin during the first stage, if labor 
had not progressed within 1 hour after random assignment, oxytocin could be 
commenced. For women with oxytocin during the first stage, it was continued during the 
second stage of labor unless there was an indication to stop the infusion. Fetal status was 
assessed by continuous electronic heart rate monitoring. Continuous-infusion epidural 
analgesia followed a standardized protocol. 
 
Duration of the expulsive efforts was prospectively collected and available for all with the 
exception of 4 patients. We categorized the duration of the active phase of the second 
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stage into four classes: less than 1 hour (h), interval 1-2h, interval 2-3h and more than 3 
hours. 
 
The primary outcome was defined as a spontaneous vaginal delivery of a newborn 
without signs of asphyxia, i.e. Apgar score at 5 minutes ≥7 and neonatal arterial pH 
>7.10 when available. Thus, indications of operative deliveries were taken into account. 
Indeed, with adequate fetal per partum surveillance, women with abnormal fetal heart 
rate monitoring had earlier operative delivery allowing birth of a newborn without signs 
of asphyxia, in comparison with women with a normal fetal heart rate. 
 
The secondary maternal outcomes were intrapartum fever, third- and fourth- degree 
perineal tears and postpartum hemorrhage (PPH) defined as blood losses greater than 
500cc with vaginal delivery and greater than 1000cc with cesarean section. The 
secondary neonatal outcomes were 5 minute Apgar score less than 7, neonatal arterial 
pH less than 7.10, any neonatal trauma (cephalhematoma, other hematoma, fracture 
and facial or brachial palsy) and admission to neonatal intensive care unit (NICU).  
 
First, we described the maternal and neonatal baseline characteristics and obstetrical 
practices in our population. Second, according to the duration of the active phase of the 
second stage, we determined the rate of spontaneous vaginal delivery with a newborn 
without sign of asphyxia in each group of randomization (immediate or delayed pushing 
groups).  Finally, we conducted univariable and multivariable analysis to assess the 
association between duration of expulsive efforts and adverse maternal or neonatal 
outcomes.  
 
Statistical analysis was performed using Stata 10.0 software (Stata Corporation, College 
Station, TX). We used the Chi-square test to compare proportions, and Fisher's exact test 
when the population size was small (n<5). To compare continuous variables, we used 
ANOVA, the variances were assessed by the Bartlett‟s test.  
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For multivariable analysis, we used unconditional logistic regression models to adjust for 
confounding. Adjusted analysis controlled for maternal age (continuous), gestational age 
(continuous), ethnic origin (categorical) , BMI at admission (continuous), birth weight 
(continuous), position of the fetal head at full dilatation (categorical), group of 
randomization (binary: early or late pushing group) and mode of delivery (categorical). 
For analysis of third- and fourth-degree tear, we also adjusted on episiotomy and its 
technique (categorical: none, median or mediolateral episiotomy). Goodness-of-fit was 
examined using the Hosmer-Lemeshow test. 
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RESULTS  
 
Maternal and neonatal characteristics are summarized in Table 1. Median duration of 
pushing efforts was 68 minutes (10th percentile: 17 min and 90th percentile: 175 min) in 
the delayed pushing group and 110 minutes (10th percentile: 37 min and 90th percentile: 
228 min) in the immediate pushing group. Six hundred and thirty five (34.2%) women 
pushed less than 1 hour, 605 (32.6%) between 1 and 2 hours, 374 (20.1%) between 2 
and 3 hours and 244 (13.1%) had an active second stage longer than 3 hours.  
 
The 5 minute Apgar score was available in 1857 cases (99.7%), but neonatal arterial pH 
was missing in 376 (20.2%) observations. As shown on Figure 1, after the first hour of 
expulsive efforts, the probability of spontaneous delivery of a baby that has no indicators 
of asphyxia decreased with time of pushing. Among women undelivered after 2 hours of 
active pushing, the chances of a spontaneous vaginal delivery of a newborn without signs 
of asphyxia were 22.7% and 19.6% in the immediate and delayed pushing groups, 
respectively. After 3 hours, it decreased to 10.7% and 8.9%. Using multivariable 
analysis, we found a significantly decreased chance for each subsequent hour to have a 
spontaneous vaginal delivery with newborn without signs of asphyxia (interval 1-2h: 
adjusted OR=0.4, 95%IC [0.3-0.6], interval 2-3h: adjusted OR=0.1, 95%IC[0.09-0.2] 
and pushing>3h: adjusted OR=0.03, 95%IC[0.02-0.1], reference: pushing<1h) (Table 
3).  
 
Univariable analysis indicated that the proportion of maternal morbidity indicators 
increased significantly with duration of the active second stage (table 2). Among women 
undelivered after 2 hours of active pushing, the rate of post partum hemorrhage was 
23.6% and it increased to 30.5% after 3 hours of pushing. The risk of operative delivery 
– instrumental extraction or cesarean section – was two-fold increased for interval 1-2h 
in comparison to those with duration of pushing less than one hour, ninefold increased 
for interval 2-3h and thirtyfold increased for pushing greater than 3 hours.  After 
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adjustment, the risk of postpartum hemorrhage increased after 2h of pushing (interval 2-
3h: adjusted OR=1.6, 95%IC[1.0-2.5] and pushing>3h: adjusted OR=2.5, 95%IC[1.5-
4.1], reference: pushing<1h). The risk of intrapartum fever was also significantly 
associated with duration of the active second stage. In the multivariable analysis, the 
risks of third- and fourth-degree tears were comparable for all classes of duration of the 
active second stage (table 3).  
 
In this context of continuous intrapartum surveillance, neonatal arterial pH and 5 minutes 
Apgar score were not influenced by pushing duration (table 2). Neonatal trauma and 
admission in NICU increased with duration of the active second stage in univariable 
analysis. After adjustment for confounding variables, none of the adverse neonatal 
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COMMENT 
 
During the active phase of the second stage, the probability of spontaneous vaginal 
delivery of a newborn with a 5 minute Apgar score ≥7 and pH at birth >7.10, decreases 
every hour. After 2 hours of pushing the risk of intra partum fever and postpartum 
hemorrhage increases significantly. However, our results suggest that in the context of 
continuous fetal surveillance in the second stage a prolonged duration of the active 
second stage does not increase the risk of adverse neonatal outcome.  
 
There are few previous publications specifically addressing the impact of the duration of 
expulsive efforts on the fetal and neonatal well-being (11-14). These studies had a small 
sample size and were focused on biological outcomes (pH and lactates). In our study, the 
population is large, homogenous (uncomplicated nulliparous women at term with 
epidural) and is derived from a multicenter trial cohort. The collection of data was 
prospective and rigorous, especially with respect to hours of pushing with only 4 subjects 
missing data. We classified pushing duration into four classes, and we demonstrated an 
increased risk for intrapartum fever and postpartum hemorrhage. In previous studies on 
this topic, some authors have oversimplified categorization of second stage (<2h and 
>2h), which limits interpretation of their results (1, 4, 5, 7). Neonatal outcomes were 
also prospectively collected in order to analyze accurately the neonatal health status. 
This reinforces the validity of our results. 
 
Previous studies concerning prolonged second stage did not differentiate passive and 
active phases, thus we cannot compare our results to those from other studies (1-7). 
However, in accordance with these studies, after adjustment, we did not find an 
association between duration of pushing and adverse neonatal outcomes. 
 
In 1973, Wood showed, among 29 patients, that neonatal arterial pH decreased to 0.003 
unit every minute of pushing (11). Other authors found similar results in small biological 
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studies (12, 14). In our study with a large sample size, where there was routine fetal 
intrapartum surveillance using fetal heart monitoring, we found no correlation between 
neonatal arterial pH values and duration of expulsive efforts. Moreover, we found a 
surprising, but non significant, decrease in the rate of arterial pH less than 7.10 after 2 
hours of pushing. This result may reflect a « healthy worker » effect, i.e. that the most 
fragile infants were probably born during the first 2 hours of pushing, if needed, by 
instrumental vaginal delivery or by cesarean section. But this result may also reflect a 
context of careful obstetrical management and an adequate fetal surveillance during the 
active second stage, performing an operative delivery when severe fetal heart rate 
abnormalities occured. Only women with normal fetal heart monitoring, were allowed to 
continue pushing after 2 hours.  
 
Because this was a secondary analysis of a randomized trial not specifically designed to 
answer the study question, our study has several limitations. We had only short-term 
data concerning maternal morbidity indicators. The effect of prolonged expulsive efforts 
on pelvic floor and continence was not assessed. Moreover, data were collected in 1994-
1996. Probably, obstetrical practices have changed since this period – fewer midpelvic 
extractions, fewer rotational procedures and more caesarean sections during the second 
stage. The operative vaginal delivery rate is high in this trial, like in other trials 
comparing delayed and immediate pushing (10). Thus, a selection bias cannot be 
excluded. In our population, most women were Caucasian or Asian. In light of the 
different prevalence of pelvic configurations in different ethnic groups, our results might 
not be generalized to ethnic groups that were under-represented in our study. Moreover, 
our results cannot be generalized to multipara and nullipara without epidural. Finally, 
because the exact duration of the first stage is difficult to estimate accurately, we did not 
adjust for it. First stage duration might have an influence on maternal and neonatal 
outcomes.  
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Sung et al. found that a second stage of labor longer than 4 hours was associated with 
an increase in unintentional hysterotomy extensions at cesarean delivery and prolonged 
operative time (15). In the PEOPLE trial, there is no data about adverse events occurring 
during caesarean such as hysterotomy extension or bladder injury. These complications 
may be more frequent in case of cesarean section after 2 or 3 hours of pushing efforts as 
compared to cesareans performed during the first two hours of active second stage.  
 
In 1989, Fusi was the first to describe an association between maternal pyrexia and the 
use of epidural in labor (16). Other authors found similar results (17). However, the 
exact influence of epidural on thermoregulation is still controversial (18). In our 
population of nullipara with epidural, there was a significantly increased risk of maternal 
intrapartum fever associated with pushing duration. We cannot determine if this result is 
due to patent infection or unbalanced thermoregulation.  
  
Analysis of risk factors associated with a prolonged active second stage could lead to the 
identification of measures to decrease the duration of expulsive efforts and the 
associated maternal morbidity. In particular, fetal malposition at full dilatation results in 
a higher risk of prolonged second stage (19). In contrast to other risk factors such as 
fetal weight, fetal malposition can be modified using simple obstetrical maneuvers. The 
routine assessment of fetal head position at full dilatation before pushing is initiated and 
the use of manual rotation might reduce the duration of pushing and the rate of cesarean 
(20-22). 
 
In our logistic regression analysis, we assessed whether the association between the risk 
of PPH and the duration of pushing was potentially mediated by the mode of delivery. 
Cesarean section is associated with both duration of pushing and risk of post-partum 
hemorrhage. The adjusted OR for PPH was significantly less than the crude OR, and the 
confidence interval for the effect excluded the null effect only when the duration of 
pushing was greater than 3 hours. It remains possible that prolonged pushing is 
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associated with technically difficult cesarean sections, where the risk of hysterotomy 
extension is increased. Thus, cesarean would be on the chain of causality between 
pushing duration and PPH.  
 
Post partum hemorrhage is well known to be a common cause of maternal mortality 
morbidity. Considering that the risk of PPH increases significantly after 2 hours of 
expulsive efforts and the chance to have a spontaneous vaginal delivery of a newborn 
without signs of asphyxia is 20% after this time, in our study, it is justified to ask the 
question as to whether operative delivery – instrumental delivery or cesarean – should 
be considered after 2 hours pushing. However, our study did not allow us to assess 
whether maternal morbidity would have been reduced if an operative delivery had been 
systematically performed after 2 hours of pushing. A policy of assisted delivery or 
cesarean after 2 hours of pushing could decrease the risk of PPH associated with uterine 
atony and difficult cesareans. But such a policy could also increase the risk of PPH due to 
an increased rate of cesarean section and instrumental delivery. Our study does not 
provide a definitive answer to that question, but does provide additional information to 
assist physician in patient‟s counseling in such situations. Our study revives the age- old 
debate as to the appropriate criteria for defining an „adequate‟, or for that matter, a 
„failed‟ trial of labor – the ultimate diagnostic conundrum in obstetrics.  This unresolved 
challenge applies both to the first and to the second stage of labor.  Only a well-designed 
randomized controlled trial comparing neonatal and maternal outcomes between 1) a 
policy of limiting pushing to 2 hours and 2) a policy of no fixed limit on the duration of 
the active second stage, will answer the question „when to stop pushing ? ‟.  
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Figure Legends: 
 
Figure 1: Probability of spontaneous vaginal delivery and birth of a newborn without sign 
of asphyxia (pH>7.10 and 5 minutes Apgar score≥7) according to pushing duration and 
the randomization group among women undelivered at the beginning of the period 
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Group of randomization 
- Late Pushing 




Maternal age in years (mean+/-SD) 28.1 +/-4.9 
Ethnic origin 







BMI at admission (mean+/-SD) 28.6 +/-4.2 
Gestational age in weeks (mean+/-SD)  39.8 +/-1.2 












Duration of pushing efforts (mean+/-SD)  
- Late Pushing group 
- Early Pushing group 
99.8 min +/-68.6 
81.8 min +/-61.2 
117.9 min +/-70.9 
Duration of pushing efforts  
- Less than 1 hour  
- Interval 1-2h  
- Interval 2-3h  
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Position of the fetal head at full dilatation  
- anterior 
- transverse 







Mode of delivery 
- spontaneous vaginal delivery  
















Birth weight in grams (mean+/-SD)  3469 +/-421 
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Table 2: Maternal and neonatal morbidity indicators according to each pushing duration 
category  
 











53 (8.4%) 75 (12.7%) 70 (19.5%) 64 (31.1%) <0.001 
3rd – 4th degree 
perineal tear 
98 (6.0%) 47 (7.8%) 52 (13.9%) 38 (15.7%) <0.001 
Intrapartum fever 21 (3.3%) 38 (6.3%) 33 (8.8%) 30 (12.3%) <0.001 











Arterial pH ≤7.10  18 (3.6%) 25 (5.2%) 5 (1.7%) 3 (1.4%) 0.020 
5 min Apgar score <7 5 (0.8%) 8 (1.3%) 3 (0.8%) 4 (1.6%) 0.566 
Neonatal trauma 34 (5.4%) 41 (6.8%) 42 (11.2%) 30 (12.3%) <0.001 
Admission in NICU 22 (3.5%) 25 (4.1%) 26 (7.0%) 21 (8.6%) 0.004 
 
*chi-square test with 3 degrees of freedom 
NICU: neonatal intensive care unit 
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Table 3: Maternal and neonatal outcomes according to pushing duration. 
Univariable and multivariable analysis, using logistic regression models  
 1-2 hours 2-3 hours > 3 hours 
 Crude OR 95%IC Adjusted OR 95%IC‡ Crude OR 95%IC Adjusted OR 95%IC‡ Crude OR 95%IC Adjusted OR 95%IC‡ 
Primary outcome: Spontaneous 
vaginal delivery of a newborn 
without sign of asphyxia 
0.4 [0.3-0.6] 0.4 [0.3-0.6] 0.1 [0.09-0.2] 0.1 [0.09-0.2] 0.03 [0.02-0.05] 0.03 [0.02-0.05] 
Operative delivery 2.3 [1.8-3.0] 2.3 [1.7-3.0] 9.3 [6.9-12.5] 9.0 [6.5-12.3] 32.9 [21.0-51.6] 31.0 [19.3-50.0] 
Post partum hemorrhage 1.6 [1.1-2.3] 1.2 [0.8-1.8] 2.6 [1.8-3.9] 1.6 [1.0-2.5] 4.9 [3.3-7.4] 2.5 [1.5-4.1] 
3rd and 4th degree perineal tear * 1.3 [0.8-2.1] 1.0 [0.6-1.6] 2.5 [1.6-3.9] 1.2 [0.7-2.0] 2.9 [1.8-4.7] 1.7 [0.9-3.0] 
Intra-partum fever  2.0 [1.1-3.4] 1.8 [1.0-3.2] 2.8 [1.6-5.0] 2.1 [1.1-4.0] 4.1 [2.3-7.3] 2.7 [1.3-5.5] 
5 minutes Apgar score  <7 1.7 [0.5-5.2] 1.1 [0.3-3.6] 1.0 [0.2-4.3] 0.4 [0.1-2.1] 2.1 [0.6-7.9] 0.7 [0.1-3.5] 
Arterial pH ≤7.10 1.5 [0.8-2.7] 1.6 [0.8-3.0] 0.5 [0.2-1.2] 0.4 [0.1-1.3] 0.4 [0.1-1.3] 0.2 [0.1-1.1] 
Neonatal trauma 1.3 [0.8-2.1] 1.2 [0.7-2.0] 2.2 [1.4-3.6] 1.5 [0.8-2.6] 2.5 [1.5-4.1] 1.7 [0.9-3.3] 
Admission in NICU  1.2 [0.7-2.2] 1.1 [0.6-2.0] 2.1 [1.2-3.7] 1.5 [0.8-3.0] 2.6 [1.5-4.9] 1.5 [0.7-3.3] 
Reference: pushing duration < 1 hour 
‡Adjustment on maternal age, gestational age, ethnic origin, BMI at the admission, birth weight, position of the fetal head at full 
dilatation, group of randomization (Early or Late Pushing), mode of delivery (excepted for the primary outcome and operative delivery) 
*Adjustment also on episiotomy and its technique (median or mediolateral)
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ANNEXE:  
The following is a list of participants in the PEOPLE Study Group. 
Steering Committee: William D. Fraser, MD, Sylvie Marcoux, MD, PhD, Isabelle Krauss, 
MD, MSc, Joanne Douglas, MD, and Céline Goulet RN, PhD.  
Center investigators and research assistants: J. Chabot, MD, J. Flamand, RN, L. 
Laperrière, BN, CHUQ–Pavillon St François d‟Assise, Quebec, Quebec, Canada; P. Fish, 
MD, and G. Hamel, RN, Hôpital de Chicoutimi, Chicoutimi, Quebec, Canada; R. Sabbah, 
MD, and L. Vincelli, RN, Hôpital Sacré-Coeur de Montréal, Montreal, Quebec, Canada; G. 
Tawagi, MD, O. Rosag, MD, and J. Belcher, RN, Ottawa Civic Hospital, Ottawa, Ontario, 
Canada; F. Galerneau, MD, M. Klein, MD, J. Swenerton, MD, B. Weibe, RN, and E. Nickel, 
RN, BC Women‟s Hospital, Vancouver, British Columbia, Canada; K. Milne, MD, J. Fuller, 
MD, and L. Watson, RN, St Joseph‟s Hospital, London, Ontario, Canada; O. Irion, MD, K. 
Rifat, MD, and V. Mentha (midwife), Hôpitaux Universitaires de Genève, Geneva, 
Switzerland; S. Bottoms, MD (deceased), and B. Steffy, RN, Hutzel Hospital, Detroit, 
Michigan; M. Helewa, MD, S. Lucy, MD, and S. Erickson, RN, St Boniface Hospital, 
Winnipeg, Manitoba, Canada; N. Okun, MD, A. Guest, MD, A. Stuart, MD, and D. 
Schimeck, RN, University of Alberta Hospital, Edmonton, Alberta, Canada; M. Sermer, 
MD, and M. Bailey, RN, Toronto General Hospital, Toronto, Ontario, Canada; and D. 
Blouin, MD, Y. Claprood, and D. Beaulieu, RN, Center Hospitalier Universitaire de l‟Estrie, 
Sherbrooke, Quebec, Canada.  
Data Management Committee: Michel Boulvain, MD, PhD, Sylvie Bérubé, PhD, and 
Isabelle Faron.  
Safety and Efficacy Monitoring Committee: François Meyer, MD, PhD, Aida Bairam, MD, 
PhD, and Jean-Marie Moutquin, MD. 
 
 
 
 
